Prescription drug · ANDA
Tafluprost NDC 0781-6184
Tafluprost .0045 mg/.3mL · Solution/ drops · Ophthalmic · Sandoz Inc
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 0781-6184-87 | 00781618487 | 6 POUCH in 1 CARTON (0781-6184-87) / 5 CONTAINER in 1 POUCH (0781-6184-14) / .3 mL in 1 CONTAINERMarketed from Dec 5, 2022 |
How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Tafluprost
- Generic name (nonproprietary)
- tafluprost
- Active ingredients
- Tafluprost — .0045 mg/.3mL
- Dosage form
- Solution/ drops
- Route
- Ophthalmic
- Labeler
- Sandoz IncNDC labeler code 0781
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 209040
- Marketing start
- Listing expires
- Other FDA classes
- Increased Prostaglandin Activity (Physiologic effect)Prostaglandin Receptor Agonists (Mechanism)Prostaglandins (Chemical structure)
- Identifiers
- Product ID 0781-6184_9cf17449-54f5-49c2-93ea-c2be06bf56cdSPL ID 9cf17449-54f5-49c2-93ea-c2be06bf56cdSPL set ID bfffa484-4105-45ec-ab1d-124e96639f35RxCUI 1244611UNII 1O6WQ6T7G3
- Pharmacologic class
- Prostaglandin Analog
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Ophthalmic products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N400781618487followed by a unit qualifier and the quantityPackage 00781-6184-87. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Tafluprost ophthalmic solution is indicated for reducing elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension. Tafluprost ophthalmic solution is a prostaglandin analog indicated for reducing elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension. ( 1 )
Excerpt only. Read the full label for complete information.
About NDC 0781-6184
- What is NDC 0781-6184?
- 0781-6184 is the product NDC for Tafluprost, Tafluprost .0045 mg/.3mL solution/ drops, listed with the FDA by Sandoz Inc. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Tafluprost.
- What is the active ingredient?
- Tafluprost.
- Who is the labeler?
- Sandoz Inc, NDC labeler code 0781. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Tafluprost?
- 2 other product NDCs are listed under this name. See all Tafluprost NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Tafluprost products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Tafluprost | Tafluprost .015 mg/mL | Solution/ dropsOphthalmic | Ingenus Pharmaceuticals, LLC | 50742-339 | 50742-0339-30 |
| tafluprosttafluprost opthalmic | Tafluprost .0045 mg/.3mL | Solution/ dropsOphthalmic | Micro Labs Limited | 42571-264 | 42571-0264-2642571-0264-7342571-0264-74 |